Showing results (271-280 of 443) with videos related to
Sort By:
Pageof 45
Cancer Research|January 7, 2006
POTE paralogs are induced and differentially expressed in many cancersTapan K Bera, Ashley Saint Fleur, Yoomi Lee, et al.Clinical Chemistry and Laboratory Medicine|December 14, 2011
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancersElad Sharon, Jingli Zhang, Kevin Hollevoet, et al.Kidney International|November 2, 2020
Stabilization of hypoxia-inducible factor ameliorates glomerular injury sensitization after tubulointerstitial injuryJun Zou, Jaewon Yang, Xiaoye Zhu, et al.The Journal of Applied Laboratory Medicine|October 30, 2018
Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung CancerYunkai Yu, Bríd M Ryan, Anish Thomas, et al.Neuro-Oncology|February 11, 2005
Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case studyJohn H Sampson, David A Reardon, Allan H Friedman, et al.Current Drug Discovery Technologies|February 21, 2012
Convection enhanced delivery of macromolecules for brain tumorsAnkit I Mehta, Bryan D Choi, Divya Ajay, et al.British Journal of Haematology|October 14, 2009
Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expressionChristian Bogner, Tobias Dechow, Ingo Ringshausen, et al.Stem Cells and Development|May 2, 2008
Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cellsTapan K Bera, Ashley Saint Fleur, Duc Ha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemiaRobert J Kreitman, Martin S Tallman, Tadeusz Robak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancerRaffit Hassan, Alan T Remaley, Maureen L Sampson, et al.Pageof 45